Pharmaceutical Microbiology (Note 2)
MCB 525
500 Level
CEPHALOSPORINS
Cephalosporin
Dose
Route
Dosing Interval
Renal
1st
Cefazolin
1-2gm
IV/IM
8
yes
Cephalothin
1-2gm
IV/IM
4-6
yes
Cephapirin
0.5-1gm
IV/IM
4-6
yes
Cephalexin
250-500mg
PO
6
yes
Cefadroxil
500mg
PO
12
yes
Cephradine
250mg
<500mg>
PO
PO
6
12
yes
2nd
Cefamandole
1-2gm
IV/IM
4-6
yes
Cefuroxime
0.75-1.5gm
250-500mg
IV/IM
PO
8
12
yes
Cefoxitin
1-2gm
IV/IM
4-6
yes
Cefotetan
1-2gm
IV/IM
12
yes
Cefmetazole
2gm
IV
6-12
yes
Cefaclor
250-500mg
PO
8
yes
Cefprozil
250-500mg
PO
12-24
yes
Cefpodoxime
200-400mg
PO
12
yes
Loracarbef
200-400mg
PO
12
yes
3rd
Cefotaxime
1-2gm
IV/IM
6-8
yes
Ceftriaxone
1-2gm
IV/IM
12-24
Ceftizoxime
1-2gm
IV/IM
8-12
yes
Ceftazidime
1-2gm
IV/IM
8
yes
Cefoperazone
1-2gm
IV/IM
12
Cefixime
400mg
200mg
PO
PO
24
12
yes
4th
Cefipime
yes
I. BACKGROUND
Cephalosporins
are beta-lactam compounds in which the beta-lactam ring is fused to a
6-membered dihydrothiazine ring, thus forming the cephem nucleus. Side chain modifications to the cephem
nucleus confers (1) an improved spectrum of antibacterial activity,( 2)
pharmacokinetic advantages, and (3) additional side effects. Cephalosporins
can be broadly categorized into four
generations.
II. MECHANISM OF ACTION & PHARMACOLOGIC PROPERTIES
1. Prevents cell wall
synthesis by binding to enzymes called penicillin binding proteins (PBPs).
These enzymes are essential for the synthesis of the bacterial cell wall.
2. Bactericidal.
3. Concentration-independent bactericidal activity, with maximal
killing at 4-5 times the MIC of the organism.
4. Clinically significant
post-antibiotic effect is not observed.
Given these pharmacodynamic properties (concentration-independent
bactericidal activity and lack of a post-antibiotic effect, optimal dosing regimens should be designed to
continuously maintain drug levels above the MIC of pathogens.
In
general, 1st generation
cephalosporins have better activity against gram-positive bacteria and
less gram-negative activity, while 3rd
generation agents, with a few exceptions, have better gram-negative activity and
less gram-positive activity. The only fourth generation agent has both
gram-positive and gram-negative activity.
It
is not uncommon for several resistance mechanisms to be operating
simultaneously.
1. destruction of beta-lactam ring by beta-lactamases; an intact beta-lactam ring is essential for
antibacterial activity
2. altered affinity of cephalosporins for their target site, the penicillin binding proteins
3. decreased penetration of antibiotic to the target site, the PBPs. This is
only applicable to gram-negative bacteria because gram-positive bacteria lack
an outer cell membrane, and therefore penetration to the target site is not a
problem.
SPECTRUM OF ACTIVITY.
PHARMACOKINETICS: Generally distributes well into the lung;
kidney; urine; synovial, pleural, and pericardial fluids. Penetration into the cerebral spinal fluid (CSF)
of some 3rd generation cephalosporins (cefotaxime, ceftriaxone, and ceftazidime) is adequate to effectively
treat bacterial meningitis.
Elimination is primarily via the kidneys, though a few exceptions include cefoperazone and
ceftriaxone which have significant biliary elimination.
GENERAL CLINICAL USES: Their broad spectrum of activity and safety
profile make the cephalosporins one of the most widely prescribed class of
antimicrobials. The earlier
generation cephalosporins are commonly used for community-acquired infections, while
the later generation agents,
with their better spectrum of activity against gram-negative bacteria make them
useful for hospital-acquired
infections or complicated community-acquired infections.
GENERAL SIDE EFFECTS/PRECAUTIONS:
A.
Hypersensitivity reactions manifested
by rashes, eosinophilia, fever (1-3%); interstitial nephritis. Given the
structural similarity of cephalosporins and penicillins, an estimated 1-7% of patients with penicillin allergies
will also be hypersensitive to cephalosporins. Cephalosporins should be avoided in patients
with immediate allergic reactions to penicillins (eg: anaphylaxis,
bronchospasm, hypotension, etc.). Cephalosporins may be tried with caution in patients with delayed
or mild reactions to penicillin.
B. Thrombophlebitis (1-5%).
Cephalosporin
|
Dose
|
Route
|
Dosing Interval
|
Renal
|
1st
|
||||
Cefazolin
|
1-2gm
|
IV/IM
|
8
|
yes
|
Cephalothin
|
1-2gm
|
IV/IM
|
4-6
|
yes
|
Cephapirin
|
0.5-1gm
|
IV/IM
|
4-6
|
yes
|
Cephalexin
|
250-500mg
|
PO
|
6
|
yes
|
Cefadroxil
|
500mg
|
PO
|
12
|
yes
|
Cephradine
|
250mg
<500mg> |
PO
PO |
6
12 |
yes
|
2nd
|
||||
Cefamandole
|
1-2gm
|
IV/IM
|
4-6
|
yes
|
Cefuroxime
|
0.75-1.5gm
250-500mg |
IV/IM
PO |
8
12 |
yes
|
Cefoxitin
|
1-2gm
|
IV/IM
|
4-6
|
yes
|
Cefotetan
|
1-2gm
|
IV/IM
|
12
|
yes
|
Cefmetazole
|
2gm
|
IV
|
6-12
|
yes
|
Cefaclor
|
250-500mg
|
PO
|
8
|
yes
|
Cefprozil
|
250-500mg
|
PO
|
12-24
|
yes
|
Cefpodoxime
|
200-400mg
|
PO
|
12
|
yes
|
Loracarbef
|
200-400mg
|
PO
|
12
|
yes
|
3rd
|
||||
Cefotaxime
|
1-2gm
|
IV/IM
|
6-8
|
yes
|
Ceftriaxone
|
1-2gm
|
IV/IM
|
12-24
|
|
Ceftizoxime
|
1-2gm
|
IV/IM
|
8-12
|
yes
|
Ceftazidime
|
1-2gm
|
IV/IM
|
8
|
yes
|
Cefoperazone
|
1-2gm
|
IV/IM
|
12
|
|
Cefixime
|
400mg
200mg |
PO
PO |
24
12 |
yes
|
4th
|
||||
Cefipime
|
yes
|
II. MECHANISM OF ACTION & PHARMACOLOGIC PROPERTIES
Elimination is primarily via the kidneys, though a few exceptions include cefoperazone and ceftriaxone which have significant biliary elimination.
No comments:
Post a Comment